• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA介导的基质金属蛋白酶调节在恶性肿瘤治疗与诊断中的作用

Role of microRNA-mediated MMP regulation in the treatment and diagnosis of malignant tumors.

作者信息

Li Liqin, Li Heng

机构信息

Huzhou Key Laboratory of Molecular Medicine; Huzhou Central Hospital; Huzhou, China.

The First Affiliated Hospital of Huzhou Teachers College; The First People's Hospital of Huzhou; Huzhou, China.

出版信息

Cancer Biol Ther. 2013 Sep;14(9):796-805. doi: 10.4161/cbt.25936. Epub 2013 Aug 5.

DOI:10.4161/cbt.25936
PMID:23917402
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3909548/
Abstract

Matrix metalloproteinases (MMPs) play important roles in tumor cell proliferation and apoptosis and contribute to tumor growth, angiogenesis, migration, and invasion primarily via extracellular matrix (ECM) degradation and/or the activation of pre-pro-growth factors. Recently, there has been considerable interest in the posttranscriptional regulation of MMPs via microRNAs (miRs). In this review, we highlight the complicated interactive network comprised of different MMPs and their regulating microRNAs, as well as the ways in which these interactions influence cancer development, including tumor angiogenesis, growth, invasion, and metastasis. Based on the conclusive roles that microRNAs play in the regulation of MMPs during cancer progression, we discuss the potential use of microRNA-mediated MMP regulation in the diagnosis and treatment of tumors from the clinical perspective. In particular, microRNA-mediated MMP regulation may lead to the development of promising new MMP inhibitors that target MMPs more selectively, and this approach may also target multiple molecules in a network, leading to the efficient regulation of distinct biological processes relevant to malignant tumors. A thorough understanding of the mechanisms underlying microRNA-mediated MMP regulation during tumor progression will help to provide new insights into the diagnosis and treatment of malignant tumors.

摘要

基质金属蛋白酶(MMPs)在肿瘤细胞增殖和凋亡中发挥重要作用,主要通过细胞外基质(ECM)降解和/或前体生长因子的激活,促进肿瘤生长、血管生成、迁移和侵袭。最近,通过微小RNA(miRs)对MMPs进行转录后调控引起了广泛关注。在本综述中,我们重点介绍了由不同MMPs及其调控微小RNA组成的复杂交互网络,以及这些相互作用影响癌症发展的方式,包括肿瘤血管生成、生长、侵袭和转移。基于微小RNA在癌症进展过程中对MMPs调控的决定性作用,我们从临床角度讨论了微小RNA介导的MMP调控在肿瘤诊断和治疗中的潜在应用。特别是,微小RNA介导的MMP调控可能会导致开发出更具选择性靶向MMPs的新型有前景的MMP抑制剂,并且这种方法还可能靶向网络中的多个分子,从而有效调控与恶性肿瘤相关的不同生物学过程。深入了解肿瘤进展过程中微小RNA介导的MMP调控机制,将有助于为恶性肿瘤的诊断和治疗提供新的见解。

相似文献

1
Role of microRNA-mediated MMP regulation in the treatment and diagnosis of malignant tumors.微小RNA介导的基质金属蛋白酶调节在恶性肿瘤治疗与诊断中的作用
Cancer Biol Ther. 2013 Sep;14(9):796-805. doi: 10.4161/cbt.25936. Epub 2013 Aug 5.
2
Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression.基质金属蛋白酶在神经内分泌前列腺癌的发生、转移和血管生成进展中发挥不同的作用。
Cancer Res. 2010 Mar 15;70(6):2224-34. doi: 10.1158/0008-5472.CAN-09-3515. Epub 2010 Mar 9.
3
Strategies to Target Matrix Metalloproteinases as Therapeutic Approach in Cancer.靶向基质金属蛋白酶作为癌症治疗方法的策略。
Methods Mol Biol. 2018;1731:325-348. doi: 10.1007/978-1-4939-7595-2_27.
4
Seesaw of matrix metalloproteinases (MMPs).基质金属蛋白酶(MMPs)的跷跷板效应
J Cancer Res Ther. 2016 Jan-Mar;12(1):28-35. doi: 10.4103/0973-1482.157337.
5
The role of microRNAs regulating the expression of matrix metalloproteinases (MMPs) in breast cancer development, progression, and metastasis.微小 RNA 调控基质金属蛋白酶表达在乳腺癌发生、发展和转移中的作用。
J Cell Physiol. 2019 May;234(5):5399-5412. doi: 10.1002/jcp.27445. Epub 2018 Nov 22.
6
Pleiotropic Roles of Metalloproteinases in Hematological Malignancies: an Update.金属蛋白酶在血液系统恶性肿瘤中的多效性作用:最新进展
Asian Pac J Cancer Prev. 2016;17(7):3043-51.
7
Matrix metalloproteinases in tumorigenesis: an evolving paradigm.肿瘤发生中的基质金属蛋白酶:一个不断发展的范例。
Cell Mol Life Sci. 2011 Dec;68(23):3853-68. doi: 10.1007/s00018-011-0763-x. Epub 2011 Jul 10.
8
Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs.基质金属蛋白酶(MMPs)是胶原蛋白降解中的主要细胞外基质(ECM)酶,可作为抗癌药物的靶点。
J Enzyme Inhib Med Chem. 2016;31(sup1):177-183. doi: 10.3109/14756366.2016.1161620. Epub 2016 Mar 30.
9
Matrix Metalloproteinases in Oral Cancer Pathogenesis and their Use in Therapy.口腔癌发病机制中的基质金属蛋白酶及其在治疗中的应用。
Anticancer Agents Med Chem. 2024;24(1):3-17. doi: 10.2174/0118715206270002231108071917.
10
Molecular and clinical insights of matrix metalloproteinases into cancer spread and potential therapeutic interventions.基质金属蛋白酶在癌症转移中的分子和临床见解及潜在的治疗干预。
Toxicol Appl Pharmacol. 2021 Sep 1;426:115593. doi: 10.1016/j.taap.2021.115593. Epub 2021 May 24.

引用本文的文献

1
Epithelial-Mesenchymal Transition in Cancer: Insights Into Therapeutic Targets and Clinical Implications.癌症中的上皮-间质转化:对治疗靶点及临床意义的见解
MedComm (2020). 2025 Aug 29;6(9):e70333. doi: 10.1002/mco2.70333. eCollection 2025 Sep.
2
Effect of Silymarin on Expression of micro-RNA-21 and Matrix Metalloproteinase (MMP) 2 and 9 and Tissue Inhibitors of Matrix Metalloproteinase (TIMP) 1 and 2 in Hepatocellular Carcinoma Cell Line (HepG2).水飞蓟素对肝癌细胞系(HepG2)中微小RNA-21、基质金属蛋白酶(MMP)2和9以及基质金属蛋白酶组织抑制剂(TIMP)1和2表达的影响
Med J Islam Repub Iran. 2024 Jul 9;38:78. doi: 10.47176/mjiri.38.78. eCollection 2024.
3
Matrix Metalloproteinases Inhibitors in Cancer Treatment: An Updated Review (2013-2023).基质金属蛋白酶抑制剂在癌症治疗中的应用:更新综述(2013-2023)。
Molecules. 2023 Jul 21;28(14):5567. doi: 10.3390/molecules28145567.
4
Matrix metalloproteinases as therapeutic targets in breast cancer.基质金属蛋白酶作为乳腺癌的治疗靶点
Front Oncol. 2023 Jan 19;12:1108695. doi: 10.3389/fonc.2022.1108695. eCollection 2022.
5
miR-4735-3p inhibits cell migration and invasion of gastric cancer by downregulating NEDD9.微小RNA-4735-3p通过下调NEDD9抑制胃癌细胞的迁移和侵袭。
Oncol Lett. 2022 Jun 10;24(2):253. doi: 10.3892/ol.2022.13373. eCollection 2022 Aug.
6
Caveolin-1-Derived Peptide Reduces ER Stress and Enhances Gelatinolytic Activity in IPF Fibroblasts.窖蛋白-1 衍生肽可减轻 IPF 成纤维细胞的内质网应激并增强其明胶酶活性。
Int J Mol Sci. 2022 Mar 18;23(6):3316. doi: 10.3390/ijms23063316.
7
Approaches Toward Targeting Matrix Metalloproteases for Prognosis and Therapies in Gynecological Cancer: MicroRNAs as a Molecular Driver.针对基质金属蛋白酶在妇科癌症预后和治疗中的靶向方法:微小RNA作为分子驱动因素
Front Oncol. 2022 Jan 25;11:720622. doi: 10.3389/fonc.2021.720622. eCollection 2021.
8
Distinct Metalloproteinase Expression and Functions in Systemic Sclerosis and Fibrosis: What We Know and the Potential for Intervention.系统性硬化症和纤维化中不同的金属蛋白酶表达及功能:我们所了解的情况及干预潜力
Front Physiol. 2021 Aug 27;12:727451. doi: 10.3389/fphys.2021.727451. eCollection 2021.
9
Exosomal miR-125b Exerts Anti-Metastatic Properties and Predicts Early Metastasis of Hepatocellular Carcinoma.外泌体miR-125b具有抗转移特性并可预测肝细胞癌的早期转移。
Front Oncol. 2021 Jul 27;11:637247. doi: 10.3389/fonc.2021.637247. eCollection 2021.
10
Matrix metalloproteinase contribution in management of cancer proliferation, metastasis and drug targeting.基质金属蛋白酶在癌症增殖、转移和药物靶向治疗中的作用。
Mol Biol Rep. 2021 Sep;48(9):6525-6538. doi: 10.1007/s11033-021-06635-z. Epub 2021 Aug 11.

本文引用的文献

1
Matrix metalloproteinase and its drug targets therapy in solid and hematological malignancies: an overview.基质金属蛋白酶及其药物靶点治疗实体瘤和血液系统恶性肿瘤:概述。
Mutat Res. 2013 Jul-Sep;753(1):7-23. doi: 10.1016/j.mrrev.2013.01.002. Epub 2013 Jan 28.
2
The biology of the extracellular matrix: novel insights.细胞外基质的生物学:新的见解。
Curr Opin Rheumatol. 2013 Jan;25(1):65-70. doi: 10.1097/BOR.0b013e32835b137b.
3
MiR-15b and miR-152 reduce glioma cell invasion and angiogenesis via NRP-2 and MMP-3.miR-15b 和 miR-152 通过 NRP-2 和 MMP-3 减少神经胶质瘤细胞侵袭和血管生成。
Cancer Lett. 2013 Feb 28;329(2):146-54. doi: 10.1016/j.canlet.2012.10.026. Epub 2012 Nov 7.
4
miR-143 inhibits the metastasis of pancreatic cancer and an associated signaling pathway.微小RNA-143抑制胰腺癌转移及相关信号通路。
Tumour Biol. 2012 Dec;33(6):1863-70. doi: 10.1007/s13277-012-0446-8. Epub 2012 Oct 16.
5
microRNA-101 inhibits lung cancer invasion through the regulation of enhancer of zeste homolog 2.微小RNA-101通过调控zeste同源物2增强子抑制肺癌侵袭。
Exp Ther Med. 2011 Sep;2(5):963-967. doi: 10.3892/etm.2011.284. Epub 2011 Jun 14.
6
Cigarette smoking decreases global microRNA expression in human alveolar macrophages.吸烟会降低人肺泡巨噬细胞中的全球 microRNA 表达。
PLoS One. 2012;7(8):e44066. doi: 10.1371/journal.pone.0044066. Epub 2012 Aug 29.
7
Consensus micro RNAs governing the switch of dormant tumors to the fast-growing angiogenic phenotype.共识 microRNAs 调控休眠肿瘤向快速生长的血管生成表型的转变。
PLoS One. 2012;7(8):e44001. doi: 10.1371/journal.pone.0044001. Epub 2012 Aug 31.
8
MicroRNA-146a suppresses metastatic activity in brain metastasis.miRNA-146a 抑制脑转移中的转移活性。
Mol Cells. 2012 Sep;34(3):329-34. doi: 10.1007/s10059-012-0171-6. Epub 2012 Sep 3.
9
MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN.微小RNA-26a通过靶向磷酸酶及张力蛋白同源物(PTEN)经由蛋白激酶B(AKT)信号通路增强肺癌细胞的转移潜能。
Biochim Biophys Acta. 2012 Nov;1822(11):1692-704. doi: 10.1016/j.bbadis.2012.07.019. Epub 2012 Aug 4.
10
MicroRNA-9 suppresses uveal melanoma cell migration and invasion through the NF-κB1 pathway.微小 RNA-9 通过 NF-κB1 通路抑制葡萄膜黑色素瘤细胞迁移和侵袭。
Oncol Rep. 2012 Sep;28(3):961-8. doi: 10.3892/or.2012.1905. Epub 2012 Jul 6.